Literature DB >> 30642429

Medicine in the Penal System.

Annette Opitz-Welke1, Marc Lehmann, Peter Seidel, Norbert Konrad.   

Abstract

BACKGROUND: Infectious diseases, substance dependencies, and dental diseases are the most important health problems affecting incarcerated persons. In Germany, for example, prisoners are 48 to 69 times more likely to be infected with the hepatitis C virus (HCV) than the general population, and 7 to 12 times more likely to be infected with the human immunodeficiency virus (HIV). The prevalence of mental illnesses is also markedly higher in the incarcerated than in the general population.
METHODS: This review is based on pertinent publications retrieved by a selective search in two databases (PubMed and Google Scholar) for any of the terms "health care," "primary health care," "mental health care"; "infectious disease," "opioid maintenance treatment," and "severe mental disorder" in conjunction with "prison," "jail," "detention," and "incarceration."
RESULTS: Among prisoners in German prisons, approximately 20% consume heroin, 20-50% suffer from alcohol dependency and abuse, and 70-85% smoke. The prevalence of tuberculosis in German prisons in 2002 was 0.1%. The provision of needles to incarcerated persons has a preventive effect on infection with hepatitis C, hepatitis B, and HIV, yet programs of this type have been discontinued in most penal facilities. In a systematic review, psychotic disorders were found in 3.6% (95% confidence interval [CI]: [3.1; 4.2]) of male inmates and 3.9% [95% CI: 2.7; 5.0] of female inmates. 25% of incarcerated persons suffer from attention-deficit-hyperac- tivity disorder. Persons recently released from prison have an above average mortality, largely due to drug intoxication.
CONCLUSION: An analysis of medical prescribing data reveals deficiencies in the provision of HCV treatment to all affected persons and in the provision of substitution treatment to persons with opiate dependency. In view of the known risks associated with imprisonment, greater emphasis should be placed on the provision of treatment for infectious diseases, substance dependencies, and mental illness, both in prison and in outpatient care after release.

Entities:  

Mesh:

Year:  2018        PMID: 30642429      PMCID: PMC6365676          DOI: 10.3238/arztebl.2018.0808

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  5 in total

Review 1.  [Dermatological video consultations for German prisons : Experiences from teledermatological consultations 2020 to 2022].

Authors:  B Stephan; G Girbig; M Scherer; E Blozik; M Augustin
Journal:  Dermatologie (Heidelb)       Date:  2022-09-23

2.  Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study.

Authors:  Kira von Bernuth; Peter Seidel; Julia Krebs; Marc Lehmann; Britta Neumann; Norbert Konrad; Annette Opitz-Welke
Journal:  Front Psychiatry       Date:  2020-08-12       Impact factor: 4.157

Review 3.  [Suicides in the German prison system: frequency, risk factors, and prevention].

Authors:  Annette Opitz-Welke; Norbert Konrad
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-12-29       Impact factor: 1.513

Review 4.  Opioid substitution therapy for people living in German prisons-inequality compared with civic sector.

Authors:  Heino Stöver; Daniela Jamin; Ingo Ilja Michels; Bärbel Knorr; Karlheinz Keppler; Daniel Deimel
Journal:  Harm Reduct J       Date:  2019-12-21

5.  Increased incarceration rates drive growing tuberculosis burden in prisons and jeopardize overall tuberculosis control in Paraguay.

Authors:  Víctor Guillermo Sequera; Sarita Aguirre; Gladys Estigarribia; Matteo Cellamare; Julio Croda; Jason R Andrews; Leonardo Martinez; Alberto L García-Basteiro
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.